
Trans Pharmaceuticals Private Limited
About Trans Pharmaceuticals Private Limited
Data last updated:
Trans Pharmaceuticals Private Limited is a private limited company based in Ahmednagar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24112PN2010PTC136897. Its GSTIN is 27AADCT5699J1ZM (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Sanjay Harakchand Gugle and Ganesh Vishwasrao Chintawar.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 3391 Sukhada Apartment Manik Chouk, Ahmednagar, Maharashtra, India – 414001.
As per the financials filed for FY 2021, the company reported a revenue of ₹8.48 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹12.55 Lakh (net margin -148.1%) and EBITDA of -₹5.34 Lakh (EBITDA margin -63%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 48% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹60 Lakh on record. Court records list 5 cases involving the company, including 5 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Trans Pharmaceuticals Private Limited's registered office is in Ahmednagar, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3391 Sukhada Apartment Manik Chouk, Ahmednagar, Maharashtra, India – 414001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trans Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trans Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Trans Pharmaceuticals Private Limited, buy the company report.
Financials of Trans Pharmaceuticals Private Limited
FY 2021 filings availableTrans Pharmaceuticals Private Limited reported revenue of ₹8.48 Lakh (down 85% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 85% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹8.48 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -63% | ||||
| Net Profit Margin | -148.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trans Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trans Pharmaceuticals Private Limited
Trans Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Harakchand Gugle Also directs: H.U.Gugle Biotech Private Limited | Director | 20 Jul 2010 | 16 Years 3 Months | Current |
| Ganesh Vishwasrao Chintawar | Director | 21 Sep 2015 | 11 Years 1 Months | Current |
| Satish Shankarrao Gadewar Also directs: Synergia Foods LLP, Satvix Informatics Private Limited | Director | 21 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Trans Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zrox Pharmaceuticals Private Limited | ₹8.51 Lakh (FY 2021) | -6.0% | Yamuna Nagar, Haryana, India | |||
| Hyssop Pharmaceuticals Private Limited | ₹8.5 Lakh (FY 2024) | -55.0% | Ranchi, Jharkhand, India | |||
| Endospy Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2025) | 70.0% | Pune, Maharashtra, India | |||
| Trans Pharmaceuticals Private Limitedthis company | ₹8.48 Lakh (FY 2021) | -₹12.55 Lakh | -148.1% | -85.0% | 8 | Ahmednagar, Maharashtra, India |
| Wellborn Pharmaceuticals Private Limited | ₹8.44 Lakh (FY 2018) | -43.0% | New Delhi, Delhi, India | |||
| Kon Pharmaceuticals Trading Private Limited | ₹8.43 Lakh (FY 2025) | 13.0% | Burdwan, West Bengal, India | |||
| Vagmin Pharmaceuticals Private Limited | ₹8.43 Lakh (FY 2019) | Bangalore, Karnataka, India |
To see the full peer comparison of Trans Pharmaceuticals Private Limited, buy the company report.
Auditor
Trans Pharmaceuticals Private Limited is audited by S P A Y & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P A Y & CO | FY 2021 | 132976W |
Shareholding
The shareholding of Trans Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Trans Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2014 | 10572475 | The Ahmednagar Merchants' Co-Operative Bank Limited | ₹10 Lakh | Open | |
| 11 Feb 2011 | 10305620 | The Ahmednagar Merchant'S Co-Op.Bank Ltd. | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Trans Pharmaceuticals Private Limited has 5 court cases on record: 5 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 5 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CHSCD) | Filed against the company by RPG Life Sciences Ltd. | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by RPG Life Sciences Ltd. | Disposed |
| Bombay High Court | Court case (NMCD) | Filed against the company by RPG Life Sciences Ltd. | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by RPG Life Sciences Ltd. | Disposed |
| Bombay High Court | Arbitration matter | Filed against the company by India Factoring and Finance Solutions Pvt.Ltd. | Disposed |
To see the full case history of Trans Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trans Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Trans Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Trans Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCT5699J1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trans Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trans Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Jeevan Narayan Jadhav ceased to be Director on 16 May 2019.
Frequently asked questions
Trans Pharmaceuticals is an active private limited company based in Ahmednagar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2010 (16+ years old) and is registered under CIN U24112PN2010PTC136897.
Trans Pharmaceuticals has 3 current directors:
- Sanjay Harakchand Gugle - Director
- Ganesh Vishwasrao Chintawar - Director
- Satish Shankarrao Gadewar - Director
The latest financial statements of Trans Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Trans Pharmaceuticals is 27AADCT5699J1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Trans Pharmaceuticals is U24112PN2010PTC136897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trans Pharmaceuticals has 5 court cases on record: 5 filed against it.
Trans Pharmaceuticals was incorporated on 20 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Trans Pharmaceuticals by revenue are Zrox Pharmaceuticals Private Limited, Hyssop Pharmaceuticals Private Limited, Endospy Pharmaceuticals Private Limited, Wellborn Pharmaceuticals Private Limited, Kon Pharmaceuticals Trading Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Jeevan Narayan Jadhav ceased to be Director on 16 May 2019. Ganesh Vishwasrao Chintawar was appointed as Director on 21 Sep 2015. Satish Shankarrao Gadewar was appointed as Director on 21 Sep 2015. Trans Pharmaceuticals has 4 board changes on record in total.
The registered office of Trans Pharmaceuticals is at 3391 Sukhada Apartment Manik Chouk, Ahmednagar, Maharashtra, India – 414001.
Trans Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.